Rayno Life Science Portfolio 2017
Rayno Life Science Portfolio 2017 YTD 6/15
- Top winners YTD: BLUE up 78.9%, FMI up 121.5%, RHHBY up 13%, ABBV up 12.7%.
- Top Losers YTD: GILD down 9.5%, BMY down 7%.
- XBI up 20.9%, our top pick for aggressive portfolios. More volatile than the IBB.
- Portfolio mix of large cap dividend with smaller cap growth and niche plays.
| Company | Ticker | Date | Price | Price | Perf | Price | YTD ’17 | |
| Started | 4/25 | % | 6/15/17 | % | Dividend % | |||
| Rayno Picks | ||||||||
| Abbvie | ABBV | 2/3/16 | 56.5 | 65.45 | 16 | 70.6 | 12.74 | 3.61 |
| Amgen | AMGN | 9/12/16 | 172 | 165 | -4 | 164.1 | 12.24 | 2.83 |
| bluebird bio | BLUE | 2/3/16 | 43.75 | 88.1 | 103 | 110.4 | 78.9 | – |
| Bristol Myers | BMY | 2/16/16 | 61 | 54.2 | -7.7 | 54.28 | -7.12 | 2.89 |
| Foundation Med | FMI | 7/5/16 | 20.4 | 34 | 68 | 39.2 | 121.5 | – |
| Hologic | HOLX | 12/20/16 | 40 | 44.4 | 10.1 | 44.72 | 11.5 | – |
| Gilead Sci | GILD | 2/3/16 | 85.8 | 67.3 | -20.9 | 64.81 | -9.5 | 3.25 |
| Roche ADR | RHHBY | 4/4/16 | 30.36 | 32.4 | 7.9 | 32.22 | 13 | 3.16 |
| IBB | 6/29/16 | 250 | 296 | 18.4 | 293.8 | 10.7 | ||
| XBI | 1/31/17 | 64 | 70.7 | 9.4 | 71.55 | 20.9 | ||
| QQQ | n/a | 135.13 | n/a | 139.1 | 17.4 |
Disclosure: None.
How did you like this article? Let us know so we can better customize your reading experience.
Thanks for sharing